These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15877737)

  • 1. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report.
    Gozzetti A; Cerase A; Crupi R; Raspadori D; Defina M; Bocchia M; Lauria F
    Leuk Res; 2011 Nov; 35(11):e206-8. PubMed ID: 21767877
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma.
    Harrington AM; Hari P; Kroft SH
    Am J Clin Pathol; 2009 Jul; 132(1):60-6. PubMed ID: 19864234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instability of immunophenotype in plasma cell myeloma.
    Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
    Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated cerebrospinal fluid beta-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system.
    Alsobhi EM; Hashim IA; Abdelaal MA; Aljifri AM; Alshamy AM
    Saudi Med J; 2007 Jan; 28(1):128-30. PubMed ID: 17206305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial central nervous system involvement in a case of non-secretory multiple myeloma].
    Calavia J; Loyola I; Richard C; Baro J; Recio M; Cuadrado MA; Zubizarreta A
    Sangre (Barc); 1993 Oct; 38(5):389-91. PubMed ID: 8140502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotypic analysis of myeloma cells].
    Mihara K; Harada H; Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsecretory multiple myeloma.
    Doster DR; Folds J; Gabriel DA
    Arch Pathol Lab Med; 1988 Feb; 112(2):147-50. PubMed ID: 3122703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of myelomatous meningitis.
    Ackroyd S; Swirsky D; Kay CL; Parapia LA
    Br J Haematol; 2004 Sep; 126(5):627. PubMed ID: 15327511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Abnormal cerebrospinal fluid plasma cells in a case of myeloma].
    Sato Y; Mizoguchi K; Ohta Y
    No To Shinkei; 1986 Apr; 38(4):399-403. PubMed ID: 3718784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningeal relapse in a case of B acute lymphoblastic leukemia: the role of CD56 expression.
    Cannizzo E; Carulli G; Buda G; Zucca A; Azzarà A; Orciuolo E; Petrini M
    Med Sci Monit; 2009 Feb; 15(2):CS27-29. PubMed ID: 19179973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple myeloma (IgG-kappa) infiltrating central nervous system, lymph nodes, liver, and kidneys, and with elevation of IgE].
    Toyota S; Nakamura N; Dan K
    Rinsho Ketsueki; 2004 May; 45(5):408-10. PubMed ID: 15199753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity.
    Trentin L; Miorin M; Facco M; Baesso I; Carraro S; Cabrelle A; Maschio N; Bortoli M; Binotto G; Piazza F; Adami F; Zambello R; Agostini C; Semenzato G
    Br J Haematol; 2007 Sep; 138(5):594-602. PubMed ID: 17686053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma.
    Dunphy CH; Nies MK; Gabriel DA
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):248-54. PubMed ID: 17721267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.
    Seegmiller AC; Xu Y; McKenna RW; Karandikar NJ
    Am J Clin Pathol; 2007 Feb; 127(2):176-81. PubMed ID: 17210522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD29 expressed on plasma cells is activated by divalent cations and soluble CD106 contained in the bone marrow plasma: refractory activation is associated with enhanced proliferation and exit of clonal plasma cells to circulation in multiple myeloma patients.
    Martínez-Viñambres E; García-Trujillo JA; Rodríguez-Martín E; Villar LM; Coll J; Roldán E
    Leukemia; 2012 May; 26(5):1098-105. PubMed ID: 22134715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.